(19)
(11) EP 2 866 791 A1

(12)

(43) Date of publication:
06.05.2015 Bulletin 2015/19

(21) Application number: 13788513.3

(22) Date of filing: 07.05.2013
(51) International Patent Classification (IPC): 
A61K 9/14(2006.01)
(86) International application number:
PCT/US2013/039901
(87) International publication number:
WO 2013/169739 (14.11.2013 Gazette 2013/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 07.05.2012 US 201261643487 P
15.03.2013 US 201313834094

(71) Applicants:
  • The General Hospital Corporation
    Boston, MA 02114 (US)
  • Xtuit Pharmaceuticals, Inc.
    Waltham, Massachusetts 02451 (US)

(72) Inventors:
  • JAIN, Rakesh, Kumar
    Wellesley, Massachusetts 02481 (US)
  • BOUCHER, Yves
    Belmont, Massachusetts 02478 (US)
  • CHAUHAN, Vikash, Pal, Singh
    Cambridge, Massachusetts 02138 (US)
  • DIOP-FRIMPONG, Benjamin
    Boston, Massachusetts 02131 (US)
  • KRANE, Stephen
    Cambridge, Massachusetts 02142 (US)
  • CRANE, Alan, L.
    Newton, Massachusetts 02468 (US)
  • LANGER, Robert, Samuel
    Newton, Massachusetts 02459 (US)

(74) Representative: Crease, Devanand John et al
Keltie LLP No.1 London Bridge
London SE1 9BA
London SE1 9BA (GB)

   


(54) NOVEL COMPOSITIONS AND USES OF ANTI-HYPERTENSION AGENTS FOR CANCER THERAPY